Emerging role of gasotransmitters in renal transplantation

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3067-3075

  Snijder, P M ^a   Van Den Berg, E ^a   Whiteman, M ^b   Bakker, S J L ^a   Leuvenink, H G D ^a   Van Goor, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

Carbon monoxide; Cardiovascular health; Hydrogen sulfide; Nephrology; Nitric oxide; Transplantation

Indexed keywords

CARBON MONOXIDE; GASOTRANSMITTER; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDROGEN SULFIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL ENERGY; CELL PROLIFERATION; CELL PROTECTION; CHEMICAL INTERACTION; DOWN REGULATION; GAS; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE ADHERENCE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THROMBOCYTE AGGREGATION; UPREGULATION; VASOCONSTRICTION;

CARBON MONOXIDE; CARDIOVASCULAR HEALTH; HYDROGEN SULFIDE; NEPHROLOGY; NITRIC OXIDE; TRANSPLANTATION;

ANIMALS; APOPTOSIS; CARBON MONOXIDE; CYTOPROTECTION; GASOTRANSMITTERS; HUMANS; HYDROGEN SULFIDE; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MICE; NITRIC OXIDE; OXIDATIVE STRESS; PREVALENCE; SIGNAL TRANSDUCTION;

EID: 84888342285     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12483     Document Type: Review

References (61)

1. Modis K, Coletta C, Erdelyi K, Papapetropoulos A, Szabo C., Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J 2013; 27: 601-611.
2. Teng H, Wu B, Zhao K, Yang G, Wu L, Wang R., Oxygen-sensitive mitochondrial accumulation of cystathionine beta-synthase mediated by Lon protease. Proc Natl Acad Sci USA 2013; 110: 12679-12684.
3. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
4. Rong Z, Wilson MT, Cooper CE., A model for the nitric oxide producing nitrite reductase activity of hemoglobin as a function of oxygen saturation. Nitric Oxide 2013; 33: 74-80.
5. Milsom AB, Patel NS, Mazzon E, et al. Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Nitric Oxide 2010; 22: 141-148.
6. Hanto DW, Maki T, Yoon MH, et al. Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. Am J Transplant 2010; 10: 2421-2430.
7. Wiesel P, Patel AP, Carvajal IM, et al. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 2001; 88: 1088-1094.
8. Shibuya N, Koike S, Tanaka M, et al. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun 2013; 4: 1366.
9. Whiteman M, Le Trionnaire S, Chopra M, Fox B, Whatmore J., Emerging role of hydrogen sulfide in health and disease: Critical appraisal of biomarkers and pharmacological tools. Clin Sci (Lond) 2011; 121: 459-488.
10. Bos EM, Wang R, Snijder PM, et al. Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol 2013; 24: 759-770.
11. Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
12. Sen U, Munjal C, Qipshidze N, Abe O, Gargoum R, Tyagi SC., Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 2010; 31: 442-455.
13. Li L, Fox B, Keeble J, et al. The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. J Cell Mol Med 2013; 17: 365-376.
14. Bos EM, Leuvenink HG, Snijder PM, et al. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009; 20: 1901-1905.
15. Whiteman M, Moore PK., Hydrogen sulfide and the vasculature: A novel vasculoprotective entity and regulator of nitric oxide bioavailability ? J Cell Mol Med 2009; 13: 488-507.
16. Wegiel B, Gallo D, Csizmadia E, et al. Biliverdin inhibits toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc Natl Acad Sci USA 2011; 108: 18849-18854.
17. Zhu JX, Kalbfleisch M, Yang YX, et al. Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: An analysis using real-time intravital microscopy and polymerase chain reaction. BJU Int 2012; 110 (11 Pt C): E1218-E1227.
18. Kim HS, Loughran PA, Billiar TR., Carbon monoxide decreases the level of iNOS protein and active dimer in IL-1beta-stimulated hepatocytes. Nitric Oxide 2008; 18: 256-265.
19. D'Araio E, Shaw N, Millward A, Demaine A, Whiteman M, Hodgkinson A., Hydrogen sulfide induces heme oxygenase-1 in human kidney cells. Acta Diabetol 2013; doi: 10.1007/s00592-013-0501-y [Epub ahead of print].
20. Zhao W, Wang R., H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283: H474-H480.
21. Kondo K, Bhushan S, King AL, et al. H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 2013; 127: 1116-1127.
22. Eto K, Kimura H., A novel enhancing mechanism for hydrogen sulfide-producing activity of cystathionine beta-synthase. J Biol Chem 2002; 277: 42680-42685.
23. Gaston RS, Schlessinger SD, Sanders PW, Barker CV, Curtis JJ, Warnock DG., Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 1995; 5: 1426-1433.
24. Schramm L, La M, Heidbreder E, et al. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int 2002; 61: 1423-1432.
25. Zhang XZ, Ardissino G, Ghio L, et al. L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction. Clin Nephrol 2001; 55: 453-459.
26. Dobashi K, Singh I, Orak JK, Asayama K, Singh AK., Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol Cell Biochem 2002; 240: 9-17.
27. Chatterjee PK, Patel NS, Sivarajah A, et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 2003; 63: 853-865.
28. Vos IH, Joles JA, Schurink M, et al. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection. Eur J Pharmacol 2000; 391: 31-38.
29. Du C, Jiang J, Guan Q, et al. NOS2 (iNOS) deficiency in kidney donor accelerates allograft loss in a murine model. Am J Transplant 2007; 7: 17-26.
30. Kelpke SS, Chen B, Bradley KM, et al. Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function. Kidney Int 2012; 82: 304-313.
31. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006; 6: 2903-2911.
32. Ozaki KS, Yoshida J, Ueki S, et al. Carbon monoxide inhibits apoptosis during cold storage and protects kidney grafts donated after cardiac death. Transpl Int 2012; 25: 107-117.
33. Blydt-Hansen TD, Katori M, Lassman C, et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 745-754.
34. Caumartin Y, Stephen J, Deng JP, et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 2011; 79: 1080-1089.
35. Nakao A, Faleo G, Nalesnik MA, Seda-Neto J, Kohmoto J, Murase N., Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function. Am J Physiol Renal Physiol 2009; 297: F19-F26.
36. Martins PN, Reutzel-Selke A, Jurisch A, et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006; 82: 938-944.
37. Sandouka A, Fuller BJ, Mann BE, Green CJ, Foresti R, Motterlini R., Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int 2006; 69: 239-247.
38. Xu Z, Prathapasinghe G, Wu N, Hwang SY, Siow YL, O K., Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol 2009; 297: F27-F35.
39. Tripatara P, Patel NS, Collino M, et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048.
40. Hosgood SA, Nicholson ML., Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation. Br J Surg 2010; 97: 202-209.
41. Zhao Y, Bhushan S, Yang C, et al. Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury. ACS Chem Biol 2013; 8: 1283-1290.
42. Calvert JW, Jha S, Gundewar S, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009; 105: 365-374.
43. Bouillaud F, Blachier F., Mitochondria and sulfide: A very old story of poisoning, feeding, and signaling ? Antioxid Redox Signal 2011; 15: 379-391.
44. Vuillefroy de Silly R, Coulon F, Poirier N, et al. Transplant tolerance is associated with reduced expression of cystathionine-gamma-lyase that controls IL-12 production by dendritic cells and TH-1 immune responses. Blood 2012; 119: 2633-2643.
45. Nakao A, Neto JS, Kanno S, et al. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005; 5: 282-291.
46. Lledo-Garcia E, Subira-Rios D, Rodriguez-Martinez D, et al. Sildenafil as a protecting drug for warm ischemic kidney transplants: Experimental results. J Urol 2009; 182: 1222-1225.
47. Leonard EC, Friedrich JL, Basile DP., VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F1648-F1657.
48. Tripatara P, Patel NS, Webb A, et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: Role for xanthine oxidoreductase. J Am Soc Nephrol 2007; 18: 570-580.
49. Kurata H, Takaoka M, Kubo Y, et al. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur J Pharmacol 2005; 517: 232-239.
50. Barakat N, Hussein AA, Abdel-Maboud M, El-Shair MA, Mostafa A, Abol-Enein H., Ischaemia-reperfusion injury in renal transplantation: The role of nitric oxide in an experimental rat model. BJU Int 2010; 106: 1230-1236.
51. Hosgood SA, Bagul A, Kaushik M, Rimoldi J, Gadepalli RS, Nicholson ML., Application of nitric oxide and carbon monoxide in a model of renal preservation. Br J Surg 2008; 95: 1060-1067.
52. Yates PJ, Hosgood SA, Nicholson ML., A biphasic response to nitric oxide donation in an ex vivo model of donation after cardiac death renal transplantation. J Surg Res 2012; 175: 316-321.
53. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE., Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 2005; 16: 950-958.
54. Faleo G, Neto JS, Kohmoto J, et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008; 85: 1833-1840.
55. Sener A, Tran KC, Deng JP, et al. Carbon monoxide releasing molecules inhibit cell death resulting from renal transplantation related stress. J Urol 2013; 190: 772-778.
56. Wagner M, Cadetg P, Ruf R, Mazzucchelli L, Ferrari P, Redaelli CA., Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 2003; 63: 1564-1573.
57. Bagul A, Hosgood SA, Kaushik M, Nicholson ML., Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation 2008; 85: 576-581.
58. Yoshida J, Ozaki KS, Nalesnik MA, et al. Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am J Transplant 2010; 10: 763-772.
59. Lobb I, Mok A, Lan Z, Liu W, Garcia B, Sener A., Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation. BJU Int 2012; 110 (11 Pt C): E1187-E1195.
60. Hunter JP, Hosgood SA, Patel M, Rose R, Read K, Nicholson ML., Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury. Br J Surg 2012; 99: 1665-1671.
61. Simon F, Scheuerle A, Groger M, et al. Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury. Shock 2011; 35: 156-163.